CODEX+ CELIDA Recommendations
1.5.2 - ci-build
CODEX+ CELIDA Recommendations - Local Development build (v1.5.2) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Active as of 2022-02-14 |
{
"resourceType" : "PlanDefinition",
"id" : "RecCollectionProphAnticoagulationHospitalizedCOVID19Patients",
"meta" : {
"profile" : [
🔗 "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/recommendation"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: PlanDefinition RecCollectionProphAnticoagulationHospitalizedCOVID19Patients</b></p><a name=\"RecCollectionProphAnticoagulationHospitalizedCOVID19Patients\"> </a><a name=\"hcRecCollectionProphAnticoagulationHospitalizedCOVID19Patients\"> </a><a name=\"RecCollectionProphAnticoagulationHospitalizedCOVID19Patients-en-US\"> </a><p><b>url</b>: <a href=\"PlanDefinition-RecCollectionProphAnticoagulationHospitalizedCOVID19Patients.html\">PlanDefinition Prophylactic anticoagulation in hospitalized COVID-19 patients</a></p><p><b>version</b>: 1.0</p><p><b>name</b>: 15 - Prophylactic Anticoagulation</p><p><b>title</b>: Prophylactic anticoagulation in hospitalized COVID-19 patients</p><p><b>type</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/plan-definition-type workflow-definition}\">Workflow Definition</span></p><p><b>status</b>: Active</p><p><b>experimental</b>: true</p><p><b>date</b>: 2022-02-14</p><p><b>publisher</b>: Deutsche Gesellschaft für Internistische Intensivmedizin und Notfallmedizin e.V. (DGIIN)</p><p><b>description</b>: </p><div><p>Hospitalisierte Patienten mit COVID-19 sollen in Abwesenheit von Kontraindikationen eine standardmäßige medikamentöse Thromboembolieprophylaxe mit niedermolekularem Heparin erhalten. Alternativ kann Fondaparinux zur Anwendung kommen.</p>\n</div><blockquote><p><b>action</b></p><p><b>title</b>: AntithromboticProphylaxisWithLWMH</p><p><b>description</b>: </p><div><p>Antithrombotic prophylaxis with LWMH in hospitalised COVID-19 patients</p>\n</div><p><b>code</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-common-process guideline-based-care}\">Guideline-based Care</span></p><p><b>definition</b>: <a href=\"PlanDefinition-AntithrombLWMHProphInHospitalisedCOVID19PatientsRecommPlan.html\">Antithrombotic prophylaxis with LWMH in hospitalised COVID-19 patients</a></p></blockquote><blockquote><p><b>action</b></p><p><b>title</b>: AntithromboticProphylaxisWithFondaparinux</p><p><b>description</b>: </p><div><p>Antithrombotic prophylaxis with Fondaparinux</p>\n</div><p><b>code</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-common-process guideline-based-care}\">Guideline-based Care</span></p><p><b>definition</b>: <a href=\"PlanDefinition-AntithrombFondapProphInHospitalisedCOVID19PatientsRecommPlan.html\">Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients</a></p></blockquote></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability",
"valueCode" : "computable"
},
{
"url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel",
"valueCode" : "structured"
},
{
"extension" : [
{
"url" : "method",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-action-combination-method",
"code" : "exactly"
}
]
}
},
{
"url" : "threshold",
"valuePositiveInt" : 1
}
],
"url" : "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/ext-action-combination-method"
}
],
"url" : "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommendation/prophylactic-anticoagulation",
"version" : "1.0",
"name" : "15 - Prophylactic Anticoagulation",
"title" : "Prophylactic anticoagulation in hospitalized COVID-19 patients",
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/plan-definition-type",
"code" : "workflow-definition"
}
]
},
"status" : "active",
"experimental" : true,
"date" : "2022-02-14",
"publisher" : "Deutsche Gesellschaft für Internistische Intensivmedizin und Notfallmedizin e.V. (DGIIN)",
"description" : "Hospitalisierte Patienten mit COVID-19 sollen in Abwesenheit von Kontraindikationen eine standardmäßige medikamentöse Thromboembolieprophylaxe mit niedermolekularem Heparin erhalten. Alternativ kann Fondaparinux zur Anwendung kommen.",
"action" : [
{
"title" : "AntithromboticProphylaxisWithLWMH",
"description" : "Antithrombotic prophylaxis with LWMH in hospitalised COVID-19 patients",
"code" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-common-process",
"code" : "guideline-based-care"
}
]
},
"definitionCanonical" : "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/intervention-plan/antithrombotic-prophylaxis-LMWH"
},
{
"title" : "AntithromboticProphylaxisWithFondaparinux",
"description" : "Antithrombotic prophylaxis with Fondaparinux",
"code" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-common-process",
"code" : "guideline-based-care"
}
]
},
"definitionCanonical" : "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/intervention-plan/antithrombotic-prophylaxis-fondaparinux"
}
]
}